Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: Biochemical, pathological, and clinical findings

Transplantation

Volumn 63, Issue 10, 1997, Pages 1386-1393

  Simonaro, Calogera M ^a   Haskins, Mark E ^b   Kunieda, Tetsuo ^c   Evans, Sydney M ^b   Visser, Jan W M ^d   Schuchman, Edward H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

^d NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCOSAMINOGLYCAN; N ACETYLGALACTOSAMINE 4 SULFATASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENOTYPE; IN SITU HYBRIDIZATION; LEUKOCYTE; MALE; MAROTEAUX LAMY SYNDROME; MORTALITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT; RETICULOENDOTHELIAL SYSTEM; TRACHEA; Y CHROMOSOME;

ANIMALS; ANIMALS, NEWBORN; AORTA; BONE MARROW TRANSPLANTATION; CATS; CHONDRO-4-SULFATASE; FEMALE; GRAFT SURVIVAL; HUMANS; LEUKOCYTES; MALE; MICROSCOPY, ELECTRON; MUCOPOLYSACCHARIDOSIS VI; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; TRACHEA; WHOLE-BODY IRRADIATION;

EID: 0030961365     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705270-00003     Document Type: Article

References (25)

1. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, and Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 1995: 2465.
2. Jezyk P, Haskins ME, Patterson DF. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science 1977; 198: 834.
3. Neer TM, Dial SM, Pechman R, Wang P, Giger U. Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome) in a miniature pinscher. J Vet Int Med 1992; 6: 124.
4. Yoshida M, Noguchi J, Ikadai H, Takahashi M, Nagase S. Arylsulfatase B-deficient mucopolysaccharidosis in rats. J Clin Invest 1993; 91: 1099.
5. Hoogerbrugge PM, Brouwer OF, Bordigoni P, et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. Lancet 1995; 345: 1398.
6. Krivit W, Pierpont ME, Ayaz K, et al. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). N Engl J Med 1984; 311: 1606.
7. Resnick M, Krivit W, Snover DC, et al. Pathology in the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 273.
8. McGovern MM, Ludman MD, Short MP, et al. Bone marrow transplantation in Maroteaux-Lamy syndrome (mps type 6): status 40 months after BMT. Birth Defects 1986; 22: 41.
9. Norrdin RW, Moffat KS, Thrall MA, Gasper PW. Characterization of osteopenia in feline mucopolysaccharidosis VI and evaluation of bone marrow transplantation therapy. Bone 1993; 14: 361.
10. Gasper PW, Thrall MA, Wenger DA, et al. Correction of feline arylsulfatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature 1984; 312: 467.
11. Wenger DA, Gasper PW, Thrall M, Dial SM, LeCouteur RA, Hoover EA. Bone marrow transplantation in the feline model of arylsulfatase B deficiency. Birth Defects 1986; 22: 177.
12. Kunieda T, Simonaro CM, Yoshida M, et al. Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics 1995; 29: 582.
13. Kunieda T, Xian M, Kobayashi E, Imamichi T, Moriwaki K, Toyoda Y. Sexing of mouse preimplantation embryos by detection of Y chromosome-specific sequences using polymerase chain reaction. Biol Rep 1992; 46: 692.
14. Beratis NG, Turner BM, Weiss R, Hirshhorn K. Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: cellular studies and carrier identification. Pediatr Res 1975; 9: 475.
15. Bjornsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 1993; 210: 282.
16. Schofield R. The relationship between the spleen colony-forming cell and the hematopoietic stem cell. Blood Cells 1978; 4: 7.
17. Brecher G, Ansel JD, Micklem HS, Tijo JH, Cronkite EP. Special proliferative sites are not needed for seeing and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci USA 1982; 79: 5085.
18. Schiffmann R, Medin JA, Ward JM, Stahl S, Cottler-Fox M, Karlsson S. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: successful engraftment and long-term expression of the transgene. Blood 1995; 86: 1218.
19. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993; 81: 2566.
20. Birkenmeier EH, Barker JE, Vogler CA, et al. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 1991; 78: 3081.
21. Sands MS, Barker JE, Vogler VL, Gwynn NG, Sly WS, Birkenmeier EH. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 1993; 68: 676.
22. Bienzle D, Abrams-Ogg ACG, Kruth SA, et al. Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 1994; 91: 350.
23. Barquinero J, Kiem HP, von Kalle C, et al. Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs. Blood 1995; 85: 1195.
24. Shull RM, Walker MA. Radiographic findings in a canine model of mucopolysaccharidosis I: changes associated with bone marrow transplantation. Invest Rad 1988; 23: 124.
25. Fillat C, Simonaro CM, Yeyati PL, Abkowitz JL, Haskins ME, Schuchman EH. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally-transduced mucopolysaccharidosis VI cells: prospects for gene therapy. J Clin Invest 1996; 98: 497.